Navigation Links
Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government
Date:7/22/2009

l recognize at least $8.0 million in additional raxibacumab revenue from the contract in the second quarter of 2009. Both the original purchase award and the purchase award announced today were made under the Project BioShield Act of 2004, which is designed to accelerate the development, purchase and availability of medical countermeasures for the Strategic National Stockpile. In May 2009, HGS submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for raxibacumab for the treatment of inhalation anthrax. In July 2009, the FDA notified HGS that the BLA for raxibacumab has been filed and will receive priority review. HGS will receive $10 million from the U.S. Government upon FDA licensure of raxibacumab.

About Anthrax

Anthrax infection is caused by a spore-forming bacterium, Bacillus anthracis, which multiplies in the body and produces lethal toxins. Most anthrax fatalities are caused by the irreversible effects of the anthrax toxins. Research has shown that the bacteria produce protective antigen, the key facilitator in the progression of anthrax infection at the cellular level. After protective antigen and the anthrax toxins are produced by the bacteria, protective antigen binds to the anthrax toxin receptor on cell surfaces and forms a protein-receptor complex that makes it possible for the anthrax toxins to enter the cells. Raxibacumab blocks the binding of protective antigen to cell surfaces and prevents the anthrax toxins from entering and killing the cells.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.

The Company's primary focus is rapid progress toward the commercial
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 According to the ... to reshape the look and feel of markets for ... for higher-quality ingredients will push for more branded, science-backed ... have experienced strong market growth in the last decade ... their food and cosmetics to fit a more ‘wellness’ ...
(Date:8/26/2014)... -- NeuroSigma, Inc., a Los Angeles -based ... announced that it has filed a registration statement on ... relating to a proposed initial public offering of its ... and the price range for the proposed offering have ... act as the book-running manager for the proposed offering, ...
(Date:8/26/2014)... argument has just been added to the growing ... as the next big thing in the high-tech ... materials. An international collaboration of researchers led by ... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab) has ... transfer in photo-excited MX2 materials. The recorded charge ...
(Date:8/26/2014)... AVENTURA. Fla. , Aug. 26, 2014 /PRNewswire/ ... trades under the symbol (NUUU) has two (2) ... Inc. Our two subsidiaries harness scientifically advanced technology ... NUUU,s Renuell Int,l, Inc. ... breakthrough anti-aging skin care products that is made ...
Breaking Biology Technology:Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3Competition for graphene 2Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2
... isnt worried about attracting good workers to Procter & Gambles ... in the machinery, equipment and technology used by those workers ... that produce Charmin and Bounty and Puffs have increased 50 ... Scribner, manager of the companys Green Bay plant. The last ...
... biotechnology community in Wisconsin calls itself Americas Third Coast, ... Approximately 150 companies belong to the Wisconsin Biotechnology Association ... the Big 10 campus of the University of Wisconsin. ... an average of $600 million annually in outside research ...
... -- The Congenital Heart Institute at Miami ... now utilizing VERICIS Cardiovascular Information System. VERCIS, developed by ... and is designed to improve patient care. , ,VERCIS ... echocardiography labs, giving physicians network access to cardio data ...
Cached Biology Technology:To attract investment, convince manufacturers that regulatory reform is real 2To attract investment, convince manufacturers that regulatory reform is real 3Americas Third Coast nurtures biotechnology 2Americas Third Coast nurtures biotechnology 3Americas Third Coast nurtures biotechnology 4Americas Third Coast nurtures biotechnology 5Americas Third Coast nurtures biotechnology 6Americas Third Coast nurtures biotechnology 7Americas Third Coast nurtures biotechnology 8Americas Third Coast nurtures biotechnology 9Americas Third Coast nurtures biotechnology 10Americas Third Coast nurtures biotechnology 11Americas Third Coast nurtures biotechnology 12Americas Third Coast nurtures biotechnology 13
(Date:8/26/2014)... Louis have developed algorithms to identify weak spots in ... The technology, which needs to be refined before it ... minor strains and tiny injuries in the body,s tissues ... available online Aug. 27 in the Journal of ... the nexus of the physical and life sciences. , ...
(Date:8/26/2014)... the University of Warwick have provided the first ... protein is linked to early signs of dementia. ... research found that the absence of the protein ... in the nervous system. These changes were shown ... of dementia, including restricted learning and memory formation ...
(Date:8/26/2014)... policymakers, consumers, and suppliers has prompted manufacturers to ... pollutants they emit from their smokestacks or discharge ... assess environmental performance at every step in their ... the use and recycling of their products. , ... known as life cycle engineering, which connects the ...
Breaking Biology News(10 mins):New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Lack of naturally occuring protein linked to dementia 2Yale journal explores advances in sustainable manufacturing 2
... China - BGI, the world,s largest genomic organization, today ... superior performance of RNA-Seq in predicting patient outcomes as ... by the U.S. Food and Drug Administration (FDA). The ... of the MicroArray Quality Control (MAQC), aimed at assessing ...
... 2, 2011 -- A woman goes into labor, and gives ... a nearby bassinet, or taken to the hospital nursery so ... research published in Biological Psychiatry provides new evidence ... baby. , It is standard practice in a hospital setting, ...
... tested newborn animals with an existing human drug used in ... early in life, prevents diabetes from developing in adult animals. ... become a way to prevent at-risk infants from developing type ... the later development of diabetes in this animal study," said ...
Cached Biology News:BGI to play a pivotal role in demonstrating the superior performance of RNA-Seq 2Maternal separation stresses the baby 2Animal study suggests that newborn period may be crucial time to prevent later diabetes 2
AM100 is an aqueous-based, permanent mounting media designed for use with alkaline phosphatase and immunoperoxidase stained tissue sections....
...
... Fixation Buffer, used in conjunction with ... can be used to fix and ... staining of cytokines and other cytoplasmic ... been specially formulated for reducing non-specific ...
... Abpromise for all tested applications). ... to KLH derived from within residues 400 ... acid sequence is proprietary)(Peptide available as ... ID: 55693 Swiss ...
Biology Products: